Skip to content

The randomized controlled trial of risperidone in reduction for the incidence of postoperative delirium in patients undergoing vascular surgery

The randomized controlled trial of risperidone in reduction for the incidence of postoperative delirium in patients undergoing vascular surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170724002
Enrollment
150
Registered
2017-07-24
Start date
2017-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium Risperidone postoperative delirium vascular patients

Interventions

risperidone 1 mg sublingual is given within 1 hour after the operation,listerine strip sublingual is given within 1 hour after the operation
risperidone 1 mg sublingual,listerine strip sublingual

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor
์N/A
Collaborator

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients are equal or older than 60 years old. 2. Vascular patient that have plan to operate (aorta, carotid and peripheral) who get anesthesia more than 2 hours. 3. Elective case

Exclusion criteria

Exclusion criteria: 1. Patients have cognitive impairment before surgery who get less than 24 score of Thai Mental State Examination (TMSE) 2. Patients who regularly drink alcoholic beverages and drink within the 14 days before surgery. 3. Pre&#45;operative patients who have positive delirium when test with Confusion Assessment Method for Intensive Care Unit (CAM&#45;ICU) 4. Patients with creatinine clearance < 30 ml/min 5. Patients with hepatic impairment with Child Pugh score greater than 10 6. Patients with history of risperidone allergy or history of neuroleptic malignant syndrome 7. Emergency case

Design outcomes

Primary

MeasureTime frame
incidence of postoperative delirium 7 days DSM V

Secondary

MeasureTime frame
length of hospital stay 30 days days,length of ICU stay 30 days days

Countries

Thailand

Contacts

Public ContactOrawan Pongraweewan

Siriraj Hospital

pongraweewan@yahoo.com6614317599

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026